XELJANZ
PFIZER CANADA ULC
Quick answers
Is there a shortage of XELJANZ in Canada?
No. There is no current shortage of XELJANZ 5MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
TARO-TOFACITINIB
TARO PHARMACEUTICALS INC
JAMP TOFACITINIB
JAMP PHARMA CORPORATION
DEVATIS TOFACITINIB
DEVATIS CANADA INC.
SANDOZ TOFACITINIB
SANDOZ CANADA INCORPORATED
TEVA-TOFACITINIB
TEVA CANADA LIMITED
PMS-TOFACITINIB
PHARMASCIENCE INC
DIN
02423898
Strength
5MG
Dosage Form
Tablet
Route
Oral
Active Ingredient
TOFACITINIB (TOFACITINIB CITRATE)
See all TOFACITINIB (TOFACITINIB CITRATE) products →Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from PFIZER CANADA ULC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
40MG · DIN 02511053
20MG · DIN 02511061
40MG · DIN 02511045
DIN 02544040
5MG · DIN 01947664
10MG · DIN 01947672
20MG · DIN 01947680
40MG · DIN 01947699
DIN 02237367
DIN 02237368
DIN 02237369
50MG · DIN 02401347